TY - JOUR
T1 - Heberden's Nodes and Knee Osteoarthritis–Related Osseous Structural Damage
T2 - Exploratory Study From the Osteoarthritis Initiative
AU - Haj-Mirzaian, Arya
AU - Mohajer, Bahram
AU - Guermazi, Ali
AU - Shakoor, Delaram
AU - Haugen, Ida K.
AU - Roemer, Frank W.
AU - Demehri, Shadpour
N1 - Funding Information:
The authors would like to thank the participants and staff involved in the FNIH and OAI projects. The publicly available data from the FNIH OA Biomarkers Consortium Project have been collected through several grants and direct or in-kind contributions from several entities, including AbbVie, Amgen, Arthritis Foundation, Artialis, Bioiberica, BioVendor, DePuy, Flexion Therapeutics, GSK, IBEX, IDS, Merck Serono, Quidel, Rottapharm | Madaus, Sanofi, Stryker, the Pivotal OAI MRI Analyses (POMA) study, the NIH (grant HHSN2682010000-21C), and the Osteoarthritis Research Society International.
Funding Information:
The authors would like to thank the participants and staff involved in the FNIH and OAI projects. The publicly available data from the FNIH OA Biomarkers Consortium Project have been collected through several grants and direct or inkind contributions from several entities, including AbbVie, Amgen, Arthritis Foundation, Artialis, Bioiberica, BioVendor, DePuy, Flexion Therapeutics, GSK, IBEX, IDS, Merck Serono, Quidel, Rottapharm | Madaus, Sanofi, Stryker, the Pivotal OAI MRI Analyses (POMA) study, the NIH (grant HHSN268201000021C), and the Osteoarthritis Research Society International.
Funding Information:
Methods. Five hundred seventy-five subjects from the Foundation for the National Institutes of Health project underwent clinical examination to evaluate HNs at baseline and knee MRI at baseline and 24 months. The MRI was read according to the semiquantitative MRI OA Knee Score and quantitative periarticular bone morphology measures. Adjusted linear/logistic regression models were implemented to assess the association between the presence of HNs at baseline examination and worsening of MRI-defined osseous structural damage, and odds ratios (ORs) with 95% confidence intervals (95% CIs) were calculated.
Publisher Copyright:
© 2019, American College of Rheumatology
PY - 2019/6
Y1 - 2019/6
N2 - Objective: To explore whether Heberden's nodes (HNs) could predict magnetic resonance imaging (MRI)–based knee osteoarthritis (OA)–related osseous structural progression. Methods: Five hundred seventy-five subjects from the Foundation for the National Institutes of Health project underwent clinical examination to evaluate HNs at baseline and knee MRI at baseline and 24 months. The MRI was read according to the semiquantitative MRI OA Knee Score and quantitative periarticular bone morphology measures. Adjusted linear/logistic regression models were implemented to assess the association between the presence of HNs at baseline examination and worsening of MRI-defined osseous structural damage, and odds ratios (ORs) with 95% confidence intervals (95% CIs) were calculated. Results: Comparing patients with HNs (n = 395) and patients without HNs (n = 180), more periarticular bone area expansion in the knee joint was seen in the patients with HNs over 24 months (adjusted OR [ORadj] 1.39 [95% CI 1.06, 1.83], corrected P [Pcorr] = 0.019), especially in the medial femur (ORadj 1.49 [95% CI 1.05, 2.13], Pcorr = 0.026) and lateral femur (ORadj 2.51 [95% CI 1.58, 3.97], Pcorr < 0.001), femoral notch (ORadj 1.37 [95% CI 1.02, 1.84], Pcorr = 0.04), and lateral trochlea (ORadj 1.44 [95% CI 1.08, 1.9], Pcorr = 0.012). However, a trend toward less osteophyte worsening was seen in patients with HNs in the whole knee joint (ORadj 0.63 [95% CI 0.40, 1.02], Pcorr = 0.058), particularly in the femur region (ORadj 0.54 [95% CI 0.31, 0.95], Pcorr = 0.03), compared to patients without HNs. Conclusion: The presence of HNs was associated with increased MRI-based periarticular bone area expansion, but less osteophyte worsening over 24 months in the knee joint, especially in the femoral region.
AB - Objective: To explore whether Heberden's nodes (HNs) could predict magnetic resonance imaging (MRI)–based knee osteoarthritis (OA)–related osseous structural progression. Methods: Five hundred seventy-five subjects from the Foundation for the National Institutes of Health project underwent clinical examination to evaluate HNs at baseline and knee MRI at baseline and 24 months. The MRI was read according to the semiquantitative MRI OA Knee Score and quantitative periarticular bone morphology measures. Adjusted linear/logistic regression models were implemented to assess the association between the presence of HNs at baseline examination and worsening of MRI-defined osseous structural damage, and odds ratios (ORs) with 95% confidence intervals (95% CIs) were calculated. Results: Comparing patients with HNs (n = 395) and patients without HNs (n = 180), more periarticular bone area expansion in the knee joint was seen in the patients with HNs over 24 months (adjusted OR [ORadj] 1.39 [95% CI 1.06, 1.83], corrected P [Pcorr] = 0.019), especially in the medial femur (ORadj 1.49 [95% CI 1.05, 2.13], Pcorr = 0.026) and lateral femur (ORadj 2.51 [95% CI 1.58, 3.97], Pcorr < 0.001), femoral notch (ORadj 1.37 [95% CI 1.02, 1.84], Pcorr = 0.04), and lateral trochlea (ORadj 1.44 [95% CI 1.08, 1.9], Pcorr = 0.012). However, a trend toward less osteophyte worsening was seen in patients with HNs in the whole knee joint (ORadj 0.63 [95% CI 0.40, 1.02], Pcorr = 0.058), particularly in the femur region (ORadj 0.54 [95% CI 0.31, 0.95], Pcorr = 0.03), compared to patients without HNs. Conclusion: The presence of HNs was associated with increased MRI-based periarticular bone area expansion, but less osteophyte worsening over 24 months in the knee joint, especially in the femoral region.
UR - http://www.scopus.com/inward/record.url?scp=85064665665&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064665665&partnerID=8YFLogxK
U2 - 10.1002/art.40811
DO - 10.1002/art.40811
M3 - Article
C2 - 30623610
AN - SCOPUS:85064665665
SN - 2326-5191
VL - 71
SP - 935
EP - 940
JO - Arthritis and Rheumatology
JF - Arthritis and Rheumatology
IS - 6
ER -